Rua Life Sciences Share Discussion Threads

[bsg] 08/3/2024 14:19

It will be years before we get another spike like the last.

[tomavery19] 08/3/2024 14:17

The traders see the buying and as this stock is known to spike large the herd will come in chasing it when its higher up.

[bsg] 08/3/2024 13:56

I thought that was when most traders sell?

[tomavery19] 08/3/2024 13:50

Need more buying and it will move fast. People want it up 20/30% before they buy

[rivaldo] 08/3/2024 13:46

I'm not a chartist, but it's certainly encouraging to see the share price bouncing both yesterday afternoon and today.

[rotherslade1] 08/3/2024 10:30

This is going up surely? with 2 major ranges 'squaring out'. For meaning of 'squaring the range' please google. From peak at 372 in 2012 to March 17 low at 9. 363 points. This week marks 363 weeks from March 17 low. From March 17 low at 9 to the 2020/21 top at 176.5 is 167.5 points. This week marks 169 weeks from 8/12/20 double top and 163 weeks from 21/1/21 double top so right in the ballpark if one takes the average of the double top.

Another way of squaring....High of 67.5 on 30/1/22. This week marks 57.5 weeks from that top. By taking 57.5 from 67.5 we arrive at 10 - just half a point out from yesterday's low. Does this really matter? Another example...Nov 21 high to Aug 22 low was 136 points- time of travel was 278 days so just slightly off an exact 2:1 basis.

All IMO please DYOR

Be there or be square!

[bones] 07/3/2024 14:32

Don’t see why they wouldn’t update in May/June, assuming nothing specific to report before then (eg, licensing news or new MTA). There should be stuff to update for the new investors especially. We all want to know how the divisions are doing and there should have been material reductions in costs following the reduction in R&D on the graft. Plenty to say imo.

[cfb2] 07/3/2024 14:09

Previously they've provided a trading update at the end of May, start of June. I expect they'll forgo as they'll only be reporting widening losses, which means next update is end of September for finals.

[fillspectre] 07/3/2024 12:48

When are we next expecting news from RUA? Fils.

[hedgehog11] 07/2/2024 22:17

I remember news, it used to be positive but turned negative. But at least we still had positive words, now we are reduced to cryptic messages and even they have become thin on the ground. Are we full circle yet.
One thing I can guarantee is that there are plans, probably very ambitious plans, like the one I had to retire early.

[harrogate] 07/2/2024 15:51

I now ignore all they say completely and just wait for some actual news.

[bones] 07/2/2024 15:49

Harrogate, in a word, yes!

[harrogate] 07/2/2024 13:47

Don't you find that often the words are intriguing and promising - majors visiting us etc etc - but the actions less so?

[bones] 07/2/2024 13:39

I also thought the comment in the RNS announcing Stretton's departure was intriguing, if cryptic, but opens up many possibilities of outside interest or investment:

"RUA is pursuing a number of opportunities to develop the business further and these will play a part in the future shape of the senior leadership team."

For a development to play a part in the formation of the senior leadership team suggests something of size. Whether that comes from internal sources or outside interest (more likely) remains to be seen.

[bones] 07/2/2024 12:56

Thread header now updated and cleaned up to reflect current information and shareholder lists.

[bones] 07/2/2024 00:03

Last summer at the AGM, the RUA board said they would not dilute the other businesses by raising the money (£6M approx) needed for the Vascular graft clinical trials and instead would seek outside finance, however that might manifest itself. They confirmed that in the interims in December (but did of course raise and dilute to keep heart valve financed).

In the webinar that followed, Bill was asked in Q&A about how that was going and what action was being taken to find a buyer or partner. In near enough his words, he said:

“I’m not going to speculate on company names or people we may have been speaking to. There are potential financial backers and a potential industry backer but I’m not going to speculate on what we are doing or what the detailed processes are but we are working on it.”

My own guess based on that wording of “financial backers and an industry backer” is it could be Corcym and/or their financial backers, Gyrus Capital. That would seem to make logical sense given that Corcym are already signed up for the ultimate sales distributor role worldwide. Why would that group of backers not want to throw a relatively small sum (for them) at this and help get the vascular graft through trials and the bulk of sales into their pockets? At the moment, they have a 50/50 deal on sales but that could be skewed further to Corcym in exchange for financing the trial.

All speculation on my part but in my opinion should be the bookies favourite, if the vascular graft is ever to get off the ground!

[hedgehog11] 30/1/2024 16:23

Thanks Harrogate - to confirm "Grant Thornton UK LLP ("Grant Thornton") has resigned as the Group's auditor." They resign because RUA chose to replace them, is that the normal process?

[harrogate] 30/1/2024 12:14

They haven't quit they have lost the audit after a competitive tender as it says clearly. It happens and hopefully we have saved a few bob

[hedgehog11] 30/1/2024 12:00

All quiet on the comments board after todays announcement. The auditors haven't quit because the fee has shrunk, because it won't have. I doubt Caroline's exit was enough for them to quit, despite the announcement coming the day after. So why have they? Do they feel like RUA are hiding something from them, like the terms of a grant or details of the recent fund raise. Just when you think the bottom has been reached this throws up more doubt.